John S. Kovach's Insider Trades & SAST Disclosures

John S. Kovach's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 200,000 Stock Options done . Disclosure was reported to the exchange on Nov. 6, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lixte Biotechnology Holdin...
John S. Kovach Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Nov 2022 200,000 200,000 - - Stock Options
Lixte Biotechnology Holdin...
John S. Kovach Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.75 per share. 30 Nov 2020 21,100 1,540,183 - 4.8 100,225 Common Stock
Lixte Biotechnology Holdin...
John S. Kovach Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Nov 2020 21,100 21,100 - - Warrants to Purchase Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades